5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.84▼ | 5.89▼ | 5.89▼ | 5.87▼ | 6.20▼ |
MA10 | 5.93▼ | 5.96▼ | 5.96▼ | 6.15▼ | 6.49▼ |
MA20 | 6.00▼ | 6.26▼ | 6.30▼ | 6.41▼ | 8.02▼ |
MA50 | 6.52▼ | 7.02▼ | 7.16▼ | 6.76▼ | 659.56▼ |
MA100 | 7.07▼ | 6.74▼ | 6.60▼ | 8.92▼ | 786.30▼ |
MA200 | 7.23▼ | 6.70▼ | 6.97▼ | 247.78▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | -0.003▼ | -0.022▼ | -0.072▼ | 45.788▲ |
RSI | 33.809▼ | 28.652▼ | 30.882▼ | 42.967▼ | 29.836▼ |
STOCH | 24.791 | 23.027 | 18.113▼ | 9.496▼ | 10.585▼ |
WILL %R | -84.211▼ | -92.157▼ | -92.157▼ | -94.393▼ | -93.420▼ |
CCI | -98.532 | -124.953▼ | -115.821▼ | -79.237 | -90.353 |
Wednesday, August 06, 2025 05:43 AM
Experienced cardiac electrophysiologist joins Glucotrack’s growing clinical advisory team as the Company advances its long-term CBGM through critical clinical milestonesRUTHERFORD, N.J., Aug. 06, 2025 ...
|
Thursday, July 31, 2025 05:54 AM
Company to present endocrinologist perspectives on implantable CBGM technology as it advances toward US pilot studyRUTHERFORD, N.J., July 3 ...
|
Tuesday, July 08, 2025 01:31 PM
RUTHERFORD, N.J., July 08, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 5.9918 | 5.9918 | 5.72 | 5.82 | 8,444 |
07/08/25 | 5.75 | 6.00 | 5.7001 | 5.81 | 15,218 |
06/08/25 | 5.91 | 6.088 | 5.64 | 5.88 | 21,500 |
05/08/25 | 5.97 | 6.15 | 5.79 | 5.83 | 40,678 |
04/08/25 | 5.79 | 6.215 | 5.79 | 6.02 | 189,966 |
01/08/25 | 5.97 | 6.456 | 5.81 | 6.23 | 67,100 |
31/07/25 | 6.20 | 6.493 | 6.10 | 6.15 | 27,600 |
30/07/25 | 6.52 | 6.822 | 6.27 | 6.35 | 27,000 |
29/07/25 | 6.98 | 6.98 | 6.46 | 6.57 | 43,800 |
28/07/25 | 7.19 | 7.34 | 6.85 | 6.85 | 71,548 |
|
|
||||
|
|
||||
|
|